The efficient generation of hepatocytes from human pluripotent stem cells (hPSCs) requires the induction of a proper endoderm population, broadly characterized by the expression of the cell surface marker CXCR4. Strategies to identify and isolate endoderm subpopulations predisposed to the liver fate do not exist. In this study, we generated mouse monoclonal antibodies against hESC-derived definitive endoderm with the goal of identifying cell surface markers that can be used to track the development of this germ layer and its specification to a hepatic fate. Through this approach, we identified two endoderm-specific antibodies, HDE1 and HDE2 that stain different stages of endoderm development and distinct derivative cell types.
Introduction
Human pluripotent stem cells (hPSCs) including both embryonic (hESCs) and induced pluripotent stem cells (hiPSCs) represent an unlimited source of differentiated cell types and tissues for modeling human development and disease in vitro, for developing novel cell based therapeutics and for establishing new drug discovery and predictive toxicology platforms (Cherry and Daley, 2012; Diecke et al., 2014; Fox et al., 2014; Holmgren et al., 2014; Leung et al., 2013; Medine et al., 2013; Roelandt et al., 2013; Sjogren et al., 2014; Szkolnicka et al., 2014; Trounson et al., 2012; Zhou et al., 2014) . Translating this potential of stem cells to practice is, however, dependent on the availability of directed differentiation strategies that enable the efficient, reproducible and cost effective generation of the lineage of interest. Of the different cell types that can be generated from hPSCs, substantial effort in recent years has been directed at the generation of endoderm derived lineages, specifically pancreatic beta cells for transplantation for the treatment of Type 1 diabetes and hepatocytes for predictive toxicology and drug metabolism studies (Holditch et al., 2014; Sun et al., 2013) . This effort has led to advances in our basic understanding of human development and the generation of protocols for directed differentiation of hPSCs to pancreatic and hepatic fates that yield seemingly highly enriched end stage populations (Chen et al., 2012; Ogawa et al., 2013; Pagliuca et al., 2014; Rezania et al., 2014; Si-Tayeb et al., 2010) . Despite this progress, efficiencies of differentiation vary considerably between different hPSC lines (Toivonen et al., 2013b; Vitale et al., 2012) , even with the most advanced protocols, and end stage populations are immature and in some instances contaminated with other cell types.
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The first step in the derivation of pancreatic and hepatic lineage cells from hPSCs is the induction of definitive endoderm. Sub-optimal endoderm induction is one likely cause of cell line to cell line and experiment-to-experiment variability as the non-endoderm cell types that differentiate under these conditions can influence pancreatic and hepatic differentiation and contribute to the development of heterogeneous end stage populations. The efficiency of endoderm induction is monitored through changes in gene expression patterns and/or changes in the expression of surface markers as assessed by flow cytometry (D'Amour et al., 2005) .
The latter approach provides a rapid quantitative read-out, but is dependent on the availability of antibodies against surface markers that are ideally found only on the cells of interest. Currently the markers most commonly used for monitoring endoderm induction from hPSCs are CD184 (CXCR4), CD117 (C-KIT) and EPCAM (D'Amour et al., 2005; Green et al., 2011; Jiang et al., 2013; Loh et al., 2014; Nostro et al., 2011; Ogawa et al., 2013) . When used in combination, they do provide a reasonable assessment of the efficiency of endoderm development. However, as none of these markers is endoderm specific (Kataoka et al., 1997; McGrath et al., 1999; Sherwood et al., 2007; Witte, 1990) , expression patterns can be misleading. The list of markers that can be used to monitor endoderm development has recently been extended to include CD49e and CD51 at the stage of definitive endoderm induction and CD141 and CD238 at the stage of patterning of the endoderm to a primitive gut tube stage (Brafman et al., 2013; Wang et al., 2011) . As with the above markers, these are also not specific to the endoderm lineage. Currently, there are no known endoderm specific cell surface markers that can be used to monitor endoderm induction or to isolate definitive endoderm populations from hPSC differentiation cultures.
To address this issue, we generated two monoclonal antibodies, HDE1 and possible to monitor both the endoderm induction and hepatic specification steps, enabling the optimization of hepatic differentiation from any hPSC line.
Results

HDE1 and HDE2 are specific for hESC-derived definitive endoderm
To generate endoderm specific antibodies, we used a strategy similar to the one we used to generate antibodies to mouse ESC-derived endoderm (Gadue et al., 2009 ).
Here, BALB/c mice were immunized with HES2 hESC-derived definitive endoderm using standard polyethylene-mediated fusion technology (Kohler and Milstein, 1975) .
Supernatants from 800 successfully fused clones were originally screened for cell surface reactivity with hESC-derived definitive endoderm by flow cytometry. The endoderm population used for immunization was generated by inducing hESCs as Development • Advance article embryoid bodies (EBs) with high concentrations of activin A for 4 days (day 1 to 5).
Greater than 95% of the induced population co-expressed the surface markers CXCR4, CD117 and EPCAM and more than 90% of the cells expressed the endoderm transcription factor SOX17 as determined by intracellular flow cytometry (Fig. 1A) .
The purity of the population was further documented by the lack of contaminating KDR + PDGFR + mesodermal cells (Fig. 1A) . We previously demonstrated that this endoderm population displays both pancreatic and hepatic potential Ogawa et al., 2013) .
The resulting antibodies were initially screened for their ability to recognize the day-5 endoderm population and subsequently for a lack of reactivity with hESCs and hESC-derived mesoderm and neuroectoderm. With this strategy, we identified two antibodies, HDE1 and HDE2 that displayed interesting staining patterns. Both antibodies stained a subset of the day 5 CXCR4 + endoderm population (Fig. 1B) . In contrast, the vast majority of cells in the undifferentiated hESC population (Fig. 1C (Feng et al., 2012) , and characterized as a COL4A1 + population that Development • Advance article expresses SOX17, LAMB1, SPARC, THBD and SOX7 as described ( Figure 1G ).
HDE1 stained a small subpopulation of these cells, whereas none was positive for HDE2. Collectively, these findings demonstrate that both HDE1 and HDE2 show specificity for definitive endoderm at early stages of hESC differentiation. analyses confirmed the lack of CD90 + cells in the HDE1-derived population (Fig. S1 ).
The CDX2 expressing cells segregated to the population generated from the HDE1 -CXCR4 + fraction, indicating that it is possible to separate endoderm with different fates based on HDE1 staining.
Monitoring pancreatic development with HDE1 and HDE2.
To determine if HDE1 and HDE2 stain endoderm derivatives, we next analyzed hESC-derived pancreatic and hepatic populations differentiated using previously described protocols Ogawa et al., 2013) . To generate pancreatic lineage cells, the day 7 population was treated with FGF10 for 3 days to pattern a foregut fate and then with the combination of retinoic acid (RA), cyclopamine and (Fig. 4C,D) . HDE2 also stained a subset of HPDE6 cells (Figs. 4E, S2B ).
These findings show HDE1 staining declines as endoderm is induced to a pancreatic fate. Following emergence of the pancreatic lineages, the HDE1 + population is restricted to the non-endocrine fraction of the population that may represent the developing exocrine and ductal lineages.
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Monitoring hepatic development with HDE1 and HDE2.
To monitor hepatic development we used a modification of our previous protocol, in which the cells are induced as a monolayer rather than EBs (Ogawa et al., 2015) .
Given that Activin A is already present at day 0 in this format, the kinetics of endoderm induction, as demonstrated by the staining patterns of CXCR4, CD117, EPCAM and HDE1, are accelerated by approximately 24 hours compared to those observed in the EBs (Fig. S3) . At day 7 of monolayer culture, the population was specified to a hepatic fate by culture in the presence of BMP4 and bFGF for 6 days. To further characterize the hepatic staining patterns of these antibodies, we analyzed fetal and adult liver as well as two liver carcinoma cell lines Huh7 and
HepG2. Fetal and adult hepatocytes were HDE2 + , as determined by immunostaining.
Neither population stained with HDE1 ( Fig. 6A,B) . Flow cytometric analyses were consistent with these findings and showed that HDE2, but not HDE1 stained primary hepatocytes, the entire Huh7 population and a portion of the HepG2 cell line (Figs 6C, D).
Given these staining patterns, our interpretation of the persistence of HDE1 + cells in the HES2-derived hepatic population is that they likely represent non-hepatic contaminants. Findings from cell sorting studies support this interpretation and showed that the HDE1 + fraction isolated from day 26 cultures expressed lower levels of ALB mRNA and contained significantly fewer ALB + cells than the HDE1 -fraction ( Fig. 6E; p<0 .01). Immunostaining analyses of the day 26 hESC-derived population revealed that HDE1 stains large, ALB -and AFP -cells consistent with the interpretation that they are not hepatic lineage cells (Fig. 6F ) As the levels of FOXA2
were similar in the two populations, the cells likely represent a non-hepatic endoderm-derived lineage (Fig. 6E) .
HDE1 definitive endoderm staining patterns correlate with hepatic potential
Previous studies have shown that prolonged activin signaling during endoderm induction from hPSCs enhances the hepatic potential of the population (Ogawa et al., 2013) . Since HDE1 staining increases over time during activin induction (Fig. 2, S3 ),
we next wanted to determine if the staining patterns of HDE1 correlate with these differences in potential. To address this, we analyzed H9 hESC-derived endoderm that was induced with activin for 3, 5, 7 or 9 days for the proportion of HDE1 + , CXCR4 + and CD117 + cells. These different endoderm populations were specified to a hepatic fate with bFGF and BMP4 following the activin induction step and matured to the ALB + hepatoblast stage as described above. The different populations were analyzed for the presence of ALB + and HDE2 + cells 19 days following the end of the endoderm induction step (DE), at the beginning of hepatic specification. As shown in S5 ). Notably, the levels of HDE2 staining in the final stage also correlated well with the size of the ALB + population, consistent with our earlier findings that it tracks with the developing hepatocyte-like cells (Fig. 7A ).
Kinetic analyses showed that the proportion of HDE1 + cells in all induced populations declined to less than 5% following specification with bFGF and BMP4 Development • Advance article (Fig. 7B) . The overall patterns of HDE2 staining were similar between the different groups. At the early stages of differentiation (days 3-5), the proportion of HDE2 + cells was consistently higher in the H9-derived populations than in those generated from either HES2 or H1 hESCs. The proportion of HDE2 + cells declined within 5 to 7 days of bFGF/BMP specification and then increased to reach maximal levels between days 13 and 19 (Fig. 7C) . The HDE2 profiles in the different groups at the DE+19 days time point reflected the hepatic potential of the population, as determined by the proportion of ALB + cells (Fig. 7A) . RT-qPCR analysis of the different populations at day 19 post specification showed that those derived from the 5, 7 and 9 day induced endoderm expressed higher levels of ALB than the cells derived from the 3 day induced endoderm (Fig. 7D, p<0 .05) The expression patterns of CD90 and CDX2 were opposite to that of ALB indicating that populations derived from endoderm induced for shorter periods of time contained contaminating CD90 + mesenchymal cells and CDX2 + posterior gut tube cells (Fig. 7D, p<0 .05).
Analyses of 2 hiPSC lines, BJ and MSC-iPS1 revealed similar correlations between HDE1 endoderm staining patterns and hepatic potential. With both cell lines, populations with the highest proportion of ALB + cells were generated from endoderm that was greater than 90% HDE1 positive (Figs S6A, S7A). Seven days of activin induction was sufficient to induce optimal hepatic endoderm populations from both hiPSC lines (Figs S6, S7). Molecular analyses showed that hepatic populations generated from day 3-and 5-induced BJ hiPSC endoderm expressed significantly lower levels of ALB and higher levels of CD90 and CDX2 than populations generated from day 7 and 9-induced endoderm (Fig S6C, p<0 .05). Similar patterns were observed for the MSC-iPS1 derived populations, as cells generated from the day 7-induced endoderm expressed higher levels of ALB and lower levels of CD90 and Development • Advance article CDX2 than those derived from the day 3-induced endoderm (Fig S7C, p<0 .01 and p<0.05 respectively). Taken together, these findings demonstrate that the staining patterns of HDE1 reflect differences in the hepatic potential of hPSC-derived endoderm and as such can be used be used to optimize the induction of hepatic endoderm from different hPSC lines.
Discussion
The efficient and reproducible production of highly enriched hPSC-derived populations is dependent on our ability to recapitulate key stages of embryonic Ogawa et al., 2013; Pagliuca et al., 2014; Rezania et al., 2014; Si-Tayeb et al., 2010; Spence et al., 2011) . Optimization of these differentiation steps is essential for the efficient production of these cells and is ideally monitored quantitatively by flow cytometric analyses of the expression of cell type and/or lineage specific surface makers. Currently, the efficiency of endoderm induction is routinely assessed by co-expression of CXCR4, CD117 and/or EPCAM. While useful, these markers are neither endoderm specific and nor are they able to distinguish subpopulations with different fates. The two antibodies generated and Development • Advance article characterized in this study HDE1 and HDE2, provide new tools for monitoring endoderm induction and hepatic specification.
At the early stages of development, HDE1 shows remarkable endoderm specificity and is able to discriminate endoderm and non-endoderm cell types in the differentiating populations. In the sub-optimally induced population, HDE1 staining marked the definitive endoderm fraction and enabled the isolation of these cells from the contaminating mesoderm, undifferentiated hESCs and other non-endoderm cell types. Importantly, HDE1 staining also revealed the presence of CD90 + mesoderm contaminants in optimally induced endoderm populations that were not detected based on CXCR4 staining. These findings confirm our previous studies that showed that Previous studies have shown that sustained activin/nodal signaling is essential for optimal generation of endoderm with hepatic potential (Ogawa et al., 2013; Si-Tayeb et al., 2010; Toivonen et al., 2013a) . The duration of this induction step in our culture Development • Advance article conditions was found to vary between hPSC lines and optimal timing could only be determined by measuring the proportion of ALB + cells at day 25 of culture. Our observation that the extent of HDE1 staining correlates with hepatic potential provides a new and rapid method to optimize this induction step. We observed that endoderm populations generated by sustained activin signaling (days 7-9) and comprised of >90% HDE1 + cells display high hepatic potential and a reduced capacity been shown to be expressed on hPSC-derived definitive endoderm (Brafman et al., 2013) . However, as with CXCR4, CD117 and EPCAM, neither is endoderm specific as both are expressed on the CXCR4 -population. In preliminary analyses, we found that CD49e was expressed on entire sub-optimal induced populations (70% CXCR4 + CD117 + ) between days 3 and 7 of differentiation, confirming that expression of this integrin is not endoderm specific. Using a different approach, Iwashita et al. showed that the levels of secreted CEREBERUS1 (CER1) quantified by ELISA correlated with the amount of endoderm in the culture (Iwashita et al., 2013) . While informative, the analyses cannot distinguish between CER1 secreted from visceral and definitive endoderm and the approach cannot be used to enrich populations of interest. Pan et al developed a technique (referred to as tfFACS) to FACS subpopulations of fixed endodermal cells based on transcription factor expression (Pan et al., 2011) . This method has the advantage of being able to isolate and analyze specific subsets of endoderm based on differential expression of transcription factors.
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However, as cells are fixed in the process, this approach cannot be used to carryout functional analyses of the isolated fixed populations.
In summary, we have generated and characterized two antibodies, HDE1 and HDE2
that display interesting and informative staining patterns on hPSC-derived endoderm and derivative populations. With these reagents, we were able to develop new stringent flow cytometric based analyses for monitoring the efficiency of endoderm induction and in doing so, demonstrate that populations considered to be highly enriched for endoderm by current criteria can contain residual mesoderm potential.
Additionally, we show that with the combination of staining patterns of the two antibodies, it is now possible to monitor the optimization of two stages of hepatic development, endoderm induction and hepatic specification by flow cytometry.
Together, these findings highlight the importance of stage and lineage specific markers for developing efficient and reproducible differentiation strategies for the generation of functional hPSC-derived cell types.
Material and Methods
Generation of hESC-derived endoderm for production of monoclonal antibodies HES2 hESCs were differentiated as embryoid bodies (EBs) in low cluster 6-well plates (4x10 5 cells/ml) in Serum Free Differentiation (SFD) medium (Gouon-Evans et al., 2006) supplemented with 2 mM L-glutamine (Gibco-BRL), 1 mM ascorbic acid (Sigma), 4 × 10 −4 M monothioglycerol (MTG) (Sigma), and 10 ng/ml BMP4 (R&D systems). After 24 hours (day 1), the medium was changed to SFD supplemented with 2 mM glutamine, 0.5 mM ascorbic acid, 4 × 10 −4 M MTG, 0.25 ng/ml BMP4, 2.5ng/ml bFGF, 100 ng/ml activin A for 3 days. At day4, EBs were transferred to fresh day 1 medium with 10 ng/ml VEGF. The resulting day 5 population was harvested and used for immunization for the generation of antibodies.
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Antibody production
Monoclonal antibodies were generated using standard polyethylene-mediated fusion technology (Kohler and Milstein, 1975 
HESCs and hiPSCs maintenance and differentiation
hESCs and iPSCs were cultured on irradiated mouse embryonic fibroblasts in hESC medium, as previously described (Kennedy et al., 2007) . For pancreas differentiation, hESCs were first passaged onto matrgiel-coated dishes for 24h to deplete the feeder cells. hESCs/hiPSCs were then dissociated using collagenase B (1 mg/ml) for 20 min, followed by a 1-2 min trypsin-EDTA (0.05%) treatment. Single cell suspensions were seeded in low-cluster dishes (Corning) at a 4x10 5 cells/ml density to generate EBs.
Pancreatic differentiation was then carried out as described .
Briefly, EBs were treated with 100 ng/ml Activin to generate definitive endoderm (see above). At day 5, the EBs were dissociated and the cells plated on gelatin at a concentration of 130 000 cells/cm 2 , in 50 ng/ml Activin A. At day 7, the posterior foregut was patterned with 100 ng/ml FGF10 for 3 days. The pancreatic progenitors were then induced by 50 ng/ml noggin, 250 nM KAAD-cyclopamine and 2 uM alltrans retinoic acid, for 3 days. Pancreatic maturation was then achieved by keeping the cells in 6 uM SB431542 and 50 ng/ml noggin. For liver differentiation, the definitive endoderm was either induced as EBs (as described above), or as monolayer (Ogawa et al., 2015) . For the monolayer induction, the hESCs were passaged on matrigel-coated dishes and cultured for 24h at a concentration of 40000 cells/cm 2 in hESC medium. Following this step, the cells were induced with 100ng/ml ActivinA Development • Advance article (R&D Systems) and 1uM CHIR 99021 for 1 day in RPMI supplemented with 2 mM glutamine (Gibco-BRL) and 4.5 × 10 −4 M MTG (Sigma), then with 100ng/ml ActivinA and 1uM CHIR 99021 and 2.5ng/ml bFGF (R&D Systems) for 1 day in RPMI supplemented with glutamine, 0.5 mM ascorbic acid (Sigma), and MTG. The media was then changed to 100ng/ml ActivinA and 2.5ng/ml bFGF for an additional day in RPMI supplemented with glutamine, ascorbic acid, and MTG. For longer activin exposure the media was changed at day 3, 5, and 7 and replaced with 100ng/ml ActivinA and 2.5ng/ml bFGF in SFD supplemented with glutamine, ascorbic acid, and MTG. Hepatic differentiation was carried out as previously described (Ogawa et al., 2013) . Briefly, hepatic specification was induced from the definitive endoderm (DE) with 40 ng/ml bFGF (20 ng/ml for Hes2) and 50 ng/ml BMP4, for 6 days (DE+6 days). At DE+6 days, the medium was changed to 20 ng/ml HGF, 40 ng/ml dexamethasone, 20 ng/ml oncostatin M, until DE+16 days. At DE+16, HGF was removed from the culture medium. For cardiac mesoderm and cardiomyocyte differentiation, hESCs were processed as described (Kattman et al., 2011) . Hematopoietic mesoderm induction was carried as described previously (Kennedy et al., 2012) . Neuroectoderm differentiation was perfomed as described (Chambers et al., 2009) .
Flow cytometry and cell sorting
Cells were trypsinized and resuspended in PBS+10% Knockout serum replacement (Gibco). For cell surface proteins, cells were stained in PBS+10% Knockout serum replacement. For intracellular staining, cells were first fixed in 2 to 4% paraformaldehyde in PBS for 20 min at room temperature. Cells were then permeabilized on ice in 90% methanol in PBS for 20 minutes, and stained in PBS+0.3%BSA+0.3%tritonX-100 (Krutzik and Nolan, 2003 Figure 3C ,D, the sorted and presort populations were plated on matrigel-coated 12-well plates at a density if 600,000 cells/well.
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Immunohistochemistry
Cells were fixed with 4% paraformaldehyde for 20 minutes at room temperature, permeabelized in 0.2% triton-X for 20 minutes at room temperature, and then blocked in PBS+2%BSA+10% secondary antibody-specific serum for 45 minutes at room temperature. Incubations with primary and secondary antibodies were performed in PBS+0.05% triton-X+2% BSA. DAPI was used for nuclei staining. Pictures of immunostained cells were acquired using a Leica CTR6000 fluorescence microscope and the Leica Application Suite software. For co-staining with HDE1 or HDE2, fixed cells were first blocked and stained with HDE1/2 and secondary antibody in PBS+2%BSA, then permeabilized and stained for intracellular proteins. The antibodies and concentrations are listed in Table S1 -S3.
Real Time PCR analysis
Total RNA was extracted with the RNAqueous-Micro Kit (Ambion) and DNase treated (Ambion). Reverse transcription was performed with 1 μg RNA using Superscript III Reverse Transcriptase (Invitrogen). QPCR was done in a MasterCycler EP RealPlex (Eppendorf) using QuantiFast SYBR Green PCR Kit (Qiagen). The fetal liver sample was a pool of 63 spontaneously aborted fetus (22-40 weeks, Clontech, cat # 636540, lot # 7030173). Primer sequences are listed in table S4. Analysis of expression levels was performed using the delta-CT method, using TBP (TATA Binding Protein) as the housekeeping gene and the control sample value set to 1.
Tissue sections and Cell lines
The fetal pancreas frozen sections came from a 40-week-old male fetus (Biochain, cat # T1244188). The fetal liver frozen sections originate from a 20-week-old female fetus (Biochain, cat#T6244700-1). Cadaveric donor tissues were used as the source of adult pancreas and adult liver sections, and these tissues were obtained thru the OHSU tissue donation program. The HPDE6 cells were a gift from Senthil K. Muthuswamy (UHN, Toronto). The human primary hepatocytes were purchased from Celsis In Vitro Technologies, (Baltimore, USA, lot# OSI). The liver carcinoma cells HepG2 and Huh7 were a gift from Dr Rebecca R. Laposa (University of Toronto).
Statistical Analysis
Statistical Analysis was performed using the one-way ANOVA and paired t-tests. 
